FDA Announces Labeling Change for Low Testosterone Medications; Warns of Increased Risk of Heart Attack and Stroke with Use

April 1st, 2015

The Food and Drug Administration (FDA) recently announced that they will be increasing restrictions on the labeling and sale of medication aimed at treating low levels of testosterone in adult men. For years, drug manufacturers have marketed medications such as Androgel, Axiron, and many others, as a “cure” for many of the symptoms associated with the normal aging process of adult men.

According to these advertisements, problems such as lowered libido, erectile dysfunction, decreased energy levels and loss of muscle tissue, could be blamed on a condition called “Low-T.” The truth of the matter is that “Low-T” is not a real medical condition; it is one that the pharmaceutical companies made up to make money. The sale and advertising of these medications is another example of drug manufacturers creating a false medical condition and playing on the insecurities of men in order to sell medication and boost prescription numbers.

In 2013 alone, the sale of testosterone replacement therapies and Low-Testosterone medications generated nearly $2 billion in revenues, up from only $324 million a decade earlier in 2002. In addition, the numbers of Low-T prescriptions issued by doctors rose from 1.3 million in 2010, to over 2.3 million in 2013.

What the drug manufacturers did not share with these patients or their doctors, is that these medications should not be consumed by men who are experiencing lower levels of testosterone as a part of the natural ageing process, as it can dramatically increase a patient’s risk of suffering a heart attack or stroke.

In reality, these types of testosterone therapy medications should only be prescribed to men suffering from a very specific medical condition known as Hypogonadism. Hypogonadism is caused by a disorder in the brain, pituitary gland or testicles, and can lead to dangerously low levels of testosterone in some older males.

Recent findings released by the FDA and several other national health organizations indicate that prescribing these medications to adult men that are not suffering from Hypogonadism may dramatically increase a patient’s risk of suffering a heart attack or stroke. Here are some concerning statistics regarding the increased risk of heart attack and stroke among men who have taken Low-T medication without a proper medical diagnosis:

  • In 2013, the Journal Of American Medical Association (JAMA) found that men who were taking testosterone replacement drugs were up to 30% more likely to suffer death, heart attacks or strokes as compared to men of the same age that were not taking such medication.
  • The National Institute of Health (NIH) also released a study that found that men taking Low-T medications past the age of 65 had nearly double the rate of heart attacks as compared to men of the same age that were not taking such medication.
  • The FDA estimates that 2.3 million men were taking Low-T medication in 2013. Of that 2.3 million, only 25% of patients had been medically diagnosed with low levels of testosterone.

As of March 3rd, 2015, The FDA will now require that patients undergo laboratory testing confirming the presence of Hypogonadism, or similar medical conditions, before prescribing these types of testosterone replacement medications. It will also will require drug manufacturers to clearly state the associated risks of taking these drugs without the proper medical diagnosis, and “change their labeling to clarify the approved uses of these medications.”

By advertising Low-T medication as safe for use in millions of men who needed no such hormone replacement therapy, drug manufacturers potentially put millions of consumers at risk. These potentially dangerous drugs have affected many healthy men.

If you or someone you love has suffered a heart attack or stroke after taking any Low-T or testosterone replacement medications, call The Yost Legal Group right away at 1-800-YOST-LAW (967-8529).

At The Yost Legal Group, Baltimore Product Liability and Defective Drug law firm, we take pride in standing up to major drug companies on behalf of our clients. When you call our firm, you will speak with an experienced Baltimore, Maryland Defective Drug attorney that will help you understand the details of your case. We know how to fight the insurance companies and major drug manufacturers in order to secure the maximum compensation for your serious injuries.

The Yost Legal Group works closely with you to gather the medical evidence needed to support your case, and we offer a free consultation to evaluate your claim.

The Yost Legal Group – Experienced Lawyers Dedicated to Protecting Your Rights

AbbVie Hit with $150M Verdict in “Low-T” Trial

The first jury verdict in a series of bellwether trials involving the testosterone treatment AndroGel is in. The jury found that the manufacturer of the gel, AbbVie, should pay $150 million in punitive damages to Oregon resident Jesse Mitchell. After seeing a commercial about AndroGel and using the product for 4 years, Mr. Mitchell suffered a nearly fatal heart attack. He testified that he would not have used the drug if AbbVie had properly warned…

Read More »

First Testosterone Gel Trial to Begin in June

The first of seven multidistrict litigation (MDL) trials involving testosterone therapy gel products begins on June 5, 2017 in the U.S District Court for the Northern District of Illinois.  About 7,000 individual cases have been filed in this MDL. The Plaintiffs allege that over a dozen pharmaceutical companies unethically and aggressively marketed testosterone replacement therapy drugs to treat symptoms of normal male aging. AbbVie Inc. and Abbott Laboratories face most of the claims in the…

Read More »

European Union Agrees with FDA, Testosterone Therapy Is Too Risky for All defective drug lawyers baltimore, product liability, medical malpractice lawyers maryland, low testosterone therapy

The leading Medical Associations in the United States and European Union have reached a consensus on therapies promising to treat low levels of testosterone in older men, a condition also known as “Low-T.” The U.S Food and Drug Administration (FDA) has already issued warnings about the use of Testosterone therapy treatments, advising consumers that the medications significantly raise the risk of serious blood clot and cardiac conditions. The European Union’s European Medicines Agency (EMA) reached…

Read More »

Low Testosterone Therapy is Causing Serious Adverse Reactions

Testosterone lawsuits are being filed throughout the country.  The Yost Legal Group defective drugs lawyers are actively investigating testosterone lawsuits for heart attack, stroke, pulmonary embolism and death. Reliable scientific studies confirm Testosterone supplementation dramatically increases the risk of these side effects in men who are healthy or have a prior heart condition. If your loved one has suffered heart attack, stroke, blood clot or death after initiating testosterone therapy, call the experienced testosterone lawyers…

Read More »